Future Drug Discovery

 

Aims & Scope
 

Future Drug Discovery is a peer-reviewed journal covering the latest breakthrough science in drug discovery, research & development. The journal strives to drive drug discovery by taking a multi-disciplinary and forward-looking stance, presenting new advances and discussing their applications and translation. Future Drug Discovery is also a forum for discussing the field at large. 

The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal's scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. 

 

---

 

Submissions

 

Submissions of the following article types are considered:  

• Case Histories (detailed reviews of a particular drug’s story, from conception to realization) 
• Editorials (short opinion pieces examining a topic of recent interest) 
• Methodologies 
• Original research 
• Perspectives (opinion-based review-length articles
• Reviews

 

---

 

Publications

 

The journal publishes original research covering the entire drug discovery pipeline, plus topics of interest to the drug discovery community, including: 

• Open science in drug discovery 
• Omics technologies 
• Computational chemistry & informatics 
• Biotechnology 
• Drug targeting & delivery 
• Pharmacokinetics & toxicology 
• Preclinical & early phase clinical studies 
• IP & pharmacoeconomics 
• Drug regulation & market analysis 
• Biopharmaceuticals & large molecules including biologics, biosimilars, vaccines, etc 
• Small molecules & medicinal chemistry 
• Natural products 
• Diagnostic approaches 
• Drug repurposing 
• Target discovery & validation 
• High-throughput screening & assay development 
• Rational drug design 
• Structural biology & biophysics 
• Hit-to-lead & lead optimization

 

---

 

For Authors

 

Future Drug Discovery provides readers the rigorous publication standards and article production quality they expect from the Future Science Group, with all articles subject to review by a minimum of two independent experts. The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY-NC-ND license. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy. The journal meets open access mandates. 

 

Managing Editor: Francesca Lake (to contact, please click here) 

 
Articles published in Future Drug Discovery include both unsolicited submissions and articles commissioned by the Editor in collaboration with the Editorial Advisory Board. For a list of the journal's Editorial Board members, please click here.